DUBbing down innate immunity
- 1 October 2004
- journal article
- editorial
- Published by Springer Nature in Nature Immunology
- Vol. 5 (10) , 1010-1012
- https://doi.org/10.1038/ni1004-1010
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responsesNature Immunology, 2004
- TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin ChainsPublished by Elsevier ,2004
- The Kinase Activity of Rip1 Is Not Required for Tumor Necrosis Factor-α-induced IκB Kinase or p38 MAP Kinase Activation or for the Ubiquitination of Rip1 by Traf2Journal of Biological Chemistry, 2004
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004
- RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activationNature Immunology, 2004
- Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activityBiochemical Journal, 2004
- The novel functions of ubiquitination in signalingCurrent Opinion in Cell Biology, 2004
- Putting the Brakes on Cylindromatosis?New England Journal of Medicine, 2004
- TLRs: Differential Adapter Utilization by Toll-Like Receptors Mediates TLR-Specific Patterns of Gene ExpressionMolecular Interventions, 2003
- TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB PathwayJournal of Molecular Biology, 2003